New eBook helps sites in their search for the perfect CTMS
Selecting a clinical trial management system (CTMS) that fits your needs can be a challenging task. That’s why Forte Research Systems, creators of Allegro [email protected]® and Allegro [email protected]®, recently released an eBook titled, “Selecting a CTMS: A How-To Guide to Selecting the Right Clinical Trial Management System.” This new guide covers everything from CTMS basics to finding vendors, preparing for multiple system demonstrations, and rating what you see. In addition to the book itself, two supplemental worksheets are available to help you with information gathering as well as with the scoring process.
To get a free download of the eBook “Selecting a CTMS,” visit http://pages.forteresearch.com/selecting-a-ctms.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Arcus’ Quemliclustat Earns Orphan Drug Designation as Phase III Pancreatic Cancer Trial Advances
July 11th 2025The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the global PRISM-1 Phase III trial nears full enrollment following promising survival data from ARC-8.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.
